Boothbay Fund Management, LLC Galapagos Nv Transaction History

Boothbay Fund Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$47.03 - $57.12 $67,205 - $81,624	-1,429 Reduced 14.03%	8,756 $483,000
Q3 2021 Nov 15, 2021	SELL	$52.17 - $70.2 $726,832 - $978,026	-13,932 Reduced 57.77%	10,185 $536,000
Q2 2021 Aug 16, 2021	SELL	$68.86 - $83.34 $38,355 - $46,420	-557 Reduced 2.26%	24,117 $1.66 Million
Q1 2021 May 17, 2021	BUY	$76.15 - $111.94 $1.88 Million - $2.76 Million	24,674 New	24,674 $1.9 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.